Presence of GAD65 autoantibodies in the serum of children with autism or ADHD

European Child and Adolescent Psychiatry

Volumn 21, Issue 3, 2012, Pages 141-147

  Rout, U K ^a   Mungan, Nils K ^a   Dhossche, Dirk M ^a  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

Author keywords

ADHD; Autism; Autoantibodies; Brain and development; GAD; Serum

Indexed keywords

GLUTAMATE DECARBOXYLASE 65 ANTIBODY; IMMUNOGLOBULIN G;

ANIMAL CELL; ANTIBODY BLOOD LEVEL; ANTIBODY TITER; ARTICLE; ATTENTION DEFICIT DISORDER; AUTISM; CEREBELLUM; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GRANULE CELL; HUMAN; HUMAN TISSUE; IMMUNOGLOBULIN BLOOD LEVEL; MALE; MENTAL DEFICIENCY; MOUSE; NONHUMAN; PURKINJE CELL; SCHOOL CHILD; SEIZURE;

ANIMALS; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; AUTISTIC DISORDER; AUTOANTIBODIES; CEREBELLUM; CHILD; FEMALE; GLUTAMATE DECARBOXYLASE; HUMANS; MALE; MICE; NEURONS;

EID: 84862843376     PISSN: 10188827     EISSN: 1435165X     Source Type: Journal    
DOI: 10.1007/s00787-012-0245-1     Document Type: Article

References (34)

1. Vianello M, Tavolato B, Giometto B (2002) Glutamic acid decarboxylase autoantibodies and neurological disorders. Neurol Sci 23(4): 145-151 (Pubitemid 35345488)
2. Blanc F, Ruppert E, Kleitz C, Valenti MP, Cretin B, Humbel RL, Honnorat J, Namer IJ, Hirsch E, Manning L et al (2009) Acute limbic encephalitis and glutamic acid decarboxylase antibodies: a reality? J Neurol Sci 287(1-2): 69-71
3. Chattopadhyay S, Ito M, Cooper JD, Brooks AI, Curran TM, Powers JM, Pearce DA (2002) An autoantibody inhibitory to glutamic acid decarboxylase in the neurodegenerative disorder Batten disease. Hum Mol Genet 11(12): 1421-1431
4. American Psychiatric Association (1994) Diagnostic and statistical manual of mental disorders, 4th edn. American Psychiatric Association, Washington
5. Yip J, Soghomonian JJ, Blatt GJ (2009) Decreased GAD65 mRNA levels in select subpopulations of neurons in the cerebellar dentate nuclei in autism: an in situ hybridization study. Autism Res 2(1): 50-59
6. Fatemi SH, Halt AR, Stary JM, Kanodia R, Schulz SC, Realmuto GR (2002) Glutamic acid decarboxylase 65 and 67 kDa proteins are reduced in autistic parietal and cerebellar cortices. Biol Psychiatry 52(8): 805-810
7. Bauman M, Kemper TL (1985) Histoanatomic observations of the brain in early infantile autism. Neurology 35(6): 866-874 (Pubitemid 15025292)
8. Rout UK, Dhossche DM (2008) A pathogenetic model of autism involving Purkinje cell loss through anti-GAD antibodies. Med Hypotheses 71(2): 218-221
9. American-Psychiatric-Association: Diagnostic and statistical manual of mental disorders: DSM-IV-TR. Book: ISBN 08904202 54 1994, Fourth Edition
10. Rommelse NN, Franke B, Geurts HM, Hartman CA, Buitelaar JK (2010) Shared heritability of attention-deficit/hyperactivity disorder and autism spectrum disorder. Eur Child Adolesc Psychiatry
11. Ronald A, Simonoff E, Kuntsi J, Asherson P, Plomin R (2008) Evidence for overlapping genetic influences on autistic and ADHD behaviours in a community twin sample. J Child Psychol Psychiatry 49(5): 535-542 (Pubitemid 351503093)
12. Lichtenstein P, Carlstrom E, Rastam M, Gillberg C, Anckarsater H (2010) The genetics of autism spectrum disorders and related neuropsychiatric disorders in childhood. Am J Psychiatry 167(11): 1357-1363
13. Pfutzner A, Forst T, Ambrosch A, Schmitz H, Lichtwald K, Beyer J (1995) Determination of anti GAD65 autoantibodies with an ELISA before and after standardization with the new international reference serum. Exp Clin Endocrinol Diabetes 103(2): 123-125
14. Sokol DK, McIntyre JA, Wagenknecht DR, Dropcho EJ, Patel H, Salanova V, da Costa G (2004) Antiphospholipid and glutamic acid decarboxylase antibodies in patients with focal epilepsy. Neurology 62(3): 517-518 (Pubitemid 38200881)
15. Kaplitt MG, Feigin A, Tang C, Fitzsimons HL, Mattis P, Lawlor PA, Bland RJ, Young D, Strybing K, Eidelberg D et al (2007) Safety and tolerability of gene therapy with an adeno-associated virus (AAV) borne GAD gene for Parkinson's disease: an open label, phase I trial. Lancet 369(9579): 2097-2105 (Pubitemid 46935946)
16. Stoop JW, Zegers BJ, Sander PC, Ballieux RE (1969) Serum immunoglobulin levels in healthy children and adults. Clin Exp Immunol 4(1): 101-112
17. Perlov E (2010) Tebarzt van Elst L, Buechert M, Maier S, Matthies S, Ebert D, Hesslinger B, Philipsen A: H(1)-MR-spectroscopy of cerebellum in adult attention deficit/hyperactivity disorder. J Psychiatr Res 44(14): 938-943
18. Wills S, Cabanlit M, Bennett J, Ashwood P, Amaral DG, Van de Water J (2009) Detection of autoantibodies to neural cells of the cerebellum in the plasma of subjects with autism spectrum disorders. Brain Behav Immun 23(1): 64-74
19. Alarcon-Segovia D, Ruiz-Arguelles A, Llorente L (1996) Broken dogma: penetration of autoantibodies into living cells. Immunol Today 17(4): 163-164 (Pubitemid 26113083)
20. Lees GJ, Horsburgh RJ (1984) Retrograde transport of dopamine beta-hydroxylase antibodies in sympathetic neurons: effects of drugs modifying noradrenergic transmission. Brain Res 301(2): 281-286 (Pubitemid 14102560)
21. Wenthold RJ, Skaggs KK, Reale RR (1984) Retrograde axonal transport of antibodies to synaptic membrane components. Brain Res 304(1): 162-165 (Pubitemid 14123327)
22. Friden PM, Olson TS, Obar R, Walus LR, Putney SD (1996) Characterization, receptor mapping and blood-brain barrier transcytosis of antibodies to the human transferrin receptor. J Pharmacol Exp Ther 278(3): 1491-1498 (Pubitemid 27167004)
23. Banks WA, Terrell B, Farr SA, Robinson SM, Nonaka N, Morley JE (2002) Passage of amyloid beta protein antibody across the blood-brain barrier in a mouse model of Alzheimer's disease. Peptides 23(12): 2223-2226 (Pubitemid 36092057)
24. Banks WA, Farr SA, Morley JE, Wolf KM, Geylis V, Steinitz M (2007) Anti-amyloid beta protein antibody passage across the blood-brain barrier in the SAMP8 mouse model of Alzheimer's disease: an age-related selective uptake with reversal of learning impairment. Exp Neurol 206(2): 248-256 (Pubitemid 47094769)
25. Burton AR, Baquet Z, Eisenbarth GS, Tisch R, Smeyne R, Workman CJ, Vignali DA (2010) Central nervous systemestruction mediated by glutamic acid decarboxylase-specific CD4? T cells. J Immunol 184(9): 4863-4870
26. Landas S, Fischer J, Wilkin LD, Mitchell LD, Johnson AK, Turner JW, Theriac M, Moore KC (1985) Demonstration of regional blood-brain barrier permeability in human brain. Neurosci Lett 57(3): 251-256 (Pubitemid 15057099)
27. Faust TW, Chang EH, Kowal C, Berlin R, Gazaryan IG, Bertini E, Zhang J, Sanchez-Guerrero J, Fragoso-Loyo HE, Volpe BT et al (2010) Neurotoxic lupus autoantibodies alter brain function through two distinct mechanisms. Proc Natl Acad Sci USA 107(43): 18569-18574
28. Tanaka S, Matsunaga H, Kimura M, Tatsumi K, Hidaka Y, Takano T, Uema T, Takeda M, Amino N (2003) Autoantibodies against four kinds of neurotransmitter receptors in psychiatric disorders. J Neuroimmunol 141(1-2): 155-164 (Pubitemid 37289009)
29. Mitoma H, Song SY, Ishida K, Yamakuni T, Kobayashi T, Mizusawa H (2000) Presynaptic impairment of cerebellar inhibitory synapses by an autoantibody to glutamate decarboxylase. J Neurol Sci 175(1): 40-44 (Pubitemid 30227482)
30. Mitoma H, Ishida K, Shizuka-Ikeda M, Mizusawa H (2003) Dual impairment of GABAA- and GABAB-receptor-mediated synaptic responses by autoantibodies to glutamic acid decarboxylase. J Neurol Sci 208(1-2): 51-56 (Pubitemid 36294154)
31. Ishida K, Mitoma H, Mizusawa H (2008) Reversibility of cerebellar GABAergic synapse impairment induced by anti-glutamic acid decarboxylase autoantibodies. J Neurol Sci 271(1-2): 186-190
32. Bauman ML, Kemper TL: The neuropathology of the autism spectrum disorders: what have we learned? Novartis Found Symp 2003, 251: 112-122; discussion 122-118, 281-197
33. Soliva JC, Moreno A, Fauquet J, Bielsa A, Carmona S, Gispert JD, Rovira M, Bulbena A, Vilarroya O (2010) Cerebellar neurometabolite abnormalities in pediatric attention/deficit hyperactivity disorder: a proton MR spectroscopic study. Neurosci Lett 470(1): 60-64
34. Mackie S, Shaw P, Lenroot R, Pierson R, Greenstein DK, Nugent TF 3rd, Sharp WS, Giedd JN, Rapoport JL (2007) Cerebellar development and clinical outcome in attention deficit hyperactivity disorder. Am J Psychiatry 164(4): 647-655 (Pubitemid 46650197)